Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.
E E
EE
van der Wall
M J
MJ
Schalij
A
A
van der Laarse
J J
JJ
Bax
D000085:Acetates; D002244:Carbon; D002304:Cardiac Pacing, Artificial / Q000009:adverse effects; D018572:Disease-Free Survival; D015150:Echocardiography, Doppler; D004734:Energy Metabolism; D006333:Heart Failure / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D020127:Recovery of Function; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
D000085:Acetates; D019275:Radiopharmaceuticals; C438206:carbon-11 acetate; D002244:Carbon